MDG1:FRA
MediGene AG
€0,017
arrow_upward
+3,61%(+0,00060) 1D
30 ມິ.ຖ., 22 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Simply Wall Street
·
41 ນາທີກ່ອນ
EBay (EBAY) Tightens Seller Rules In Australia And The US
MarketBeat
·
31 ນາທີກ່ອນ
Quantum-Si (NASDAQ:QSI) Stock Rating Raised to "Hold" at Wall Street Zen
MarketBeat
·
31 ນາທີກ່ອນ
Rush Enterprises (NASDAQ:RUSHA) Rating Lowered to Hold at Wall Street Zen
Yahoo Finance
·
7 ຊົ່ວໂມງກ່ອນ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia